Jeff Yass’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-181,957
Closed -$506K 14602
2022
Q3
$506K Buy
181,957
+6,200
+4% +$15.1K ﹤0.01% 8456
2022
Q2
$216K Buy
175,757
+44,884
+34% +$75.3K ﹤0.01% 10455
2022
Q1
$378K Buy
130,873
+14,787
+13% +$62.8K ﹤0.01% 9688
2021
Q4
$777K Buy
116,086
+88,399
+319% +$858K ﹤0.01% 7964
2021
Q3
$365K Buy
27,687
+18,315
+195% +$389K ﹤0.01% 10134
2021
Q2
$375K Buy
+9,372
New +$370K ﹤0.01% 10294

Jeff Yass's ZY Position: Q4 2022 in Review

Jeff Yass sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 181,957 shares — an estimated $506K sold.

Jeff Yass first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $777K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Jeff Yass reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 181,957 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $506K.
  • Jeff Yass first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Jeff Yass's Zymergen Inc. Common Stock position peaked at $777K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.